Becton Dickinson & Co. (BDX)

242.52
2.90 1.20
NYSE : Health Technology
Prev Close 245.42
Open 244.43
Day Low/High 242.41 / 244.74
52 Wk Low/High 208.62 / 265.87
Volume 168.32K
Avg Volume 1.09M
Exchange NYSE
Shares Outstanding 269.06M
Market Cap 66.61B
EPS 0.60
P/E Ratio 71.31
Div & Yield 3.08 (1.22%)

Latest News

BD To Present At The Barclays Global Healthcare Conference

BD To Present At The Barclays Global Healthcare Conference

FRANKLIN LAKES, N.J.

Becton, Dickinson Becomes #155 Most Shorted S&P 500 Component, Replacing AbbVie

Becton, Dickinson Becomes #155 Most Shorted S&P 500 Component, Replacing AbbVie

The most recent short interest data has been released for the 01/31/2019 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: APTV, ATAX, BDX, CBT, GS, IT, LXP, MHO, SF, SLGN, VOXX, WGP Downgrades: ADM, M, MWA, NVDA Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

'Do It Yourself' Stock Picking, GOOGL Opportunity, Disney Reports: Market Recon

'Do It Yourself' Stock Picking, GOOGL Opportunity, Disney Reports: Market Recon

The selloff in Alphabet presents opportunity, and I think this cash machine is ripe for a small long position.

BD Announces Results For 2019 First Fiscal Quarter; Reaffirms Fiscal 2019 Guidance

BD Announces Results For 2019 First Fiscal Quarter; Reaffirms Fiscal 2019 Guidance

- As reported, revenues of $4.160 billion increased 35.1 percent.

8 Earnings to Watch Before the Market Opens Tuesday

8 Earnings to Watch Before the Market Opens Tuesday

Viacom, BP and ADM among companies expected to report before the start of trading Tuesday.

BD Launches Ergonomic Pen Needle Technology To Help Optimize Injection Technique

BD Launches Ergonomic Pen Needle Technology To Help Optimize Injection Technique

BD Nano™ Second Generation Pen Needle Receives 510(k) Clearance from U.S. Food and Drug Administration

BD Board Declares Dividends

BD Board Declares Dividends

FRANKLIN LAKES, N.J.

Becton Dickinson Expects First-Quarter Earnings to Beat Wall Street Estimates

Becton Dickinson Expects First-Quarter Earnings to Beat Wall Street Estimates

Becton Dickinson sees 35.1% revenue growth for its fiscal first quarter.

BD Announces Preliminary Results For 2019 First Fiscal Quarter; Reaffirms Fiscal 2019 Guidance

BD Announces Preliminary Results For 2019 First Fiscal Quarter; Reaffirms Fiscal 2019 Guidance

- Preliminary reported revenues of $4.160 billion increased 35.1 percent.

BD Announces Webcast Of Annual Meeting Of Shareholders

BD Announces Webcast Of Annual Meeting Of Shareholders

FRANKLIN LAKES, N.J.

BD To Present At Investor Healthcare Conferences

BD To Present At Investor Healthcare Conferences

FRANKLIN LAKES, N.J.

BD Completes Molecular Portfolio For GI Infection With New Viral Panel

BD Completes Molecular Portfolio For GI Infection With New Viral Panel

BD MAX™ Enteric Viral Panel Receives 510(k) Clearance from U.S. Food and Drug Administration

Fossil’s Stock Is Getting Clocked, Plus 4 Other Worthy Short Candidates

FOSL, BDX, BIG, WGO and C were all recently downgraded by TheStreet's Quant Ratings service.

BD Announces Completion Of Enterprise Level Cybersecurity Assessment From UL

BD Announces Completion Of Enterprise Level Cybersecurity Assessment From UL

BD FACSLyric™ Flow Cytometer is First BD Product to Earn UL Cybersecurity Assurance Program Certification

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ASFI, KFY Downgrades: APAM, BDX, CKH, COTY, CWEN, CWEN.A, KOP, UUUU Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

BD Expands Integrated Medication Management To Help Tackle Hospital Drug Diversion

BD Expands Integrated Medication Management To Help Tackle Hospital Drug Diversion

Learn how advanced analytics can help combat a critical component of the opioid epidemic at the #ASHP18 Midyear Meeting

BD Board Declares Dividends

BD Board Declares Dividends

FRANKLIN LAKES, N.J.

New Diagnostic Test Helps Hospitals More Quickly Identify And Treat Emerging Antibiotic-Resistant Bacteria

New Diagnostic Test Helps Hospitals More Quickly Identify And Treat Emerging Antibiotic-Resistant Bacteria

Fully-automated BD Phoenix™ CPO Detect Test Receives U.S. FDA Clearance

BD Announces Clinical Trial Data For The LUTONIX® 014 Drug-Coated Balloon Below-The-Knee IDE Trial

BD Announces Clinical Trial Data For The LUTONIX® 014 Drug-Coated Balloon Below-The-Knee IDE Trial

Safety and efficacy results presented during late-breaking clinical trials session at VIVA 2018

BD To Present At The Stifel 2018 Healthcare Conference

BD To Present At The Stifel 2018 Healthcare Conference

FRANKLIN LAKES, N.J.

Expect Markets to Take a Breather on Election Day: Market Recon

Expect Markets to Take a Breather on Election Day: Market Recon

Things may pick up in the afternoon -- here is how to play it and what sectors to be wary of.

BD Announces Results For 2018 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2019 Guidance

BD Announces Results For 2018 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2019 Guidance

- As reported, full fiscal year revenues of $15.983 billion increased 32.2 percent.

Selloff Strategies: Cramer's 'Mad Money' Recap (Wednesday 10/10/18)

Selloff Strategies: Cramer's 'Mad Money' Recap (Wednesday 10/10/18)

Jim Cramer cautions investors to stick to their plans and be prepared for more market weakness.

ConAgra Foods, Caterpillar, FireEye: 'Mad Money' Lightning Round

ConAgra Foods, Caterpillar, FireEye: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at ConAgra Foods, Caterpillar, FireEye, Becton Dickinson, Loxo Oncology, Alibaba.

TheStreet Quant Rating: A (Buy)